CN code 294190 covers antibiotics not included under more specific subheadings within heading 2941 of the Combined Nomenclature, including lincomycin (CAS 154-21-2), vancomycin (CAS 1404-90-6), rifampicin (CAS 13292-46-1), polymyxins and other substances with antibiotic activity. Antibiotics are organic substances produced by microorganisms or synthetically, capable of inhibiting bacterial growth or destroying bacteria. Classification under heading 2941 requires compliance with Note 1 to Chapter 29 — the substance must be chemically defined, pure or containing only a diluent or stabiliser necessary for storage or transport. Finished pharmaceutical preparations containing antibiotics are classified in Chapter 30. Vancomycin and rifampicin are antibiotics used for treating serious multi-drug-resistant infections (MRSA, MDR-TB). Lincomycin belongs to the lincosamide class, polymyxins to the polypeptide class. When importing substances under 294190, it is essential to determine whether the goods are active pharmaceutical ingredients (APIs) or chemically pure substances for research or industrial use, as this entails different regulatory obligations. GRI 1 requires classification based on the wording of headings and relevant section and chapter notes. In cases of classification doubt, Binding Tariff Information (BTI) ruling from the competent customs authority is strongly recommended and is binding for 3 years throughout the EU.

Antibiotics classified under CN 294190 are subject to REACH Regulation (EC) No 1907/2006. Manufacturers and importers handling more than 1 tonne per year are required to register the substance with ECHA. A Safety Data Sheet (SDS) compliant with CLP Regulation (EC) No 1272/2008 must be provided, covering toxicological properties and hazards to human health and the environment. Vancomycin and rifampicin may be subject to SVHC listing procedures or ECHA risk assessment. Polymyxins, particularly colistin, are subject to EU restrictions regarding antibiotic resistance; their veterinary use is substantially limited under Regulation (EU) 2019/6. Where antibiotics are intended for use in medicinal products, import as APIs requires compliance with Good Manufacturing Practice (GMP) standards under Directive 2001/83/EC. Importers should verify whether any substance falls under narcotic or psychotropic precursor controls under Regulation (EC) No 273/2004 — this must be checked individually for each substance. Antibiotics intended for non-medical applications such as research must still satisfy REACH chemical safety assessment requirements. A Certificate of Analysis (CoA) with CAS number and purity specification is required by customs and pharmaceutical supervisory authorities.

The import of antibiotics under CN 294190 into the European Union is governed by the Union Customs Code (Regulation (EU) No 952/2013). Customs declarations must include the 10-digit TARIC code, as tariff suspensions, tariff quotas or trade defence measures may apply. Autonomous tariff suspensions under EU pharmaceutical raw materials regulations cover many APIs in this category at reduced or zero duty rates — verification in the TARIC database of the European Commission is essential before each import. Required documentation includes: a commercial invoice with CAS number and technical specification, a Certificate of Analysis (CoA) confirming identity and purity, CMR waybill or bill of lading, and a CLP-compliant SDS. For pharmaceutical APIs, an import authorisation from the competent national authority and a supplier GMP declaration may be required. Preferential duty rates under FTAs, GSP or GSP+ arrangements are available with appropriate proof of origin such as EUR.1 certificate, invoice declaration or REX statement. Always verify current duty rates and all applicable trade measures in TARIC before import.

Organic substances under CN code 2941 90 (Other antibiotics) require detailed chemical documentation for customs clearance. The Safety Data Sheet must comply with REACH Annex II. Substances classified as hazardous under CLP require GHS pictogram labelling. Transport follows ADR (road) or IMDG (maritime) regulations. Some organic substances may be subject to export controls as dual-use goods. Importers should verify whether the substance requires REACH authorisation (Annex XIV) or is subject to restrictions (Annex XVII).